Detailed price information for Nanoviricides Inc (NNVC-A) from The Globe and Mail including charting and trades.
Signs Master Services Agreement With Only Orphans Cote For NV-387 Orphan Drug Strategy. NanoViricides, Inc. (NYSE American: NNVC), a clinical stage global pioneer in broad-spectrum antivirals based on ...
Researchers found that rabies virus uses a shape-shifting protein to hijack RNA and control vital cell functions. Viruses are astonishingly efficient, able to take over our cells and control essential ...
SHELTON, CONNECTICUT / ACCESS Newswire / November 14, 2025 / NanoViricides, Inc. (NYSE American:NNVC) (the “Company”), a clinical stage leader developing revolutionary broad-spectrum antiviral drugs ...
SHELTON, CONNECTICUT / ACCESS Newswire / November 10, 2025 / NanoViricides, Inc. (NYSE American:NNVC) (the “Company”) today reported that it has received approval to Start Phase II Clinical Trial of ...
SHELTON, CONNECTICUT / ACCESS Newswire / November 17, 2025 / NanoViricides, Inc. (NYSE Amer.:NNVC) (the “Company”), reports that it has filed its Quarterly Report on Form 10-Q for the fiscal quarter ...
In the 1980s, the human immunodeficiency virus (HIV) was a global scourge, decimating communities. When it was identified in the blood products supply chain, people were terrified.
Infectious diseases such as bacterial, viral, fungal and parasitic diseases continue to have a significant impact on global health. Hence, knowledge on how infection spread, population vulnerable to ...
Healthbeat on MSN
How the Global Fund might cover a $6.7B shortfall in donations
This week’s Global Health Checkup has an unexpected through-line. Several stories reveal how the global health system is preparing for a long season of austerity: from staff cuts at the World Health ...
Island Pharmaceuticals Ltd ( ($AU:ILA) ) has provided an announcement. Island Pharmaceuticals Ltd has been granted a US patent for the use of ...
The government has increased public health surveillance at airports, border points and other high-risk areas after ...
The company's Check4 electrochemical detection platform can detect nucleic acid targets from blood or saliva samples in less than five minutes.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results